Women Who Enrolled in EAQ201 vs Women Who Enrolled in TMIST: Compare the Proportion of WOC in TMIST Participants vs EAQ201 Participants
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
Measures 6
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
| Measure | Value | 95% interval, lower | 95% interval, upper | Method | Note | Source |
|---|---|---|---|---|---|---|
| Risk in group 1 | 0.0714 | 0.0127 | 0.315 | wilson | ClinicalTrials.gov | |
| Risk in group 2 | 0.0693 | 0.0655 | 0.0733 | wilson | ClinicalTrials.gov | |
| Risk difference, group 1 minus group 2 | 0.00215 | -0.0567 | 0.245 | newcombe hybrid score | ClinicalTrials.gov | |
| Risk ratio, group 1 over group 2 | 1.03 | 0.156 | 6.82 | log | ClinicalTrials.gov | |
| Odds ratio, group 1 over group 2 | 1.03 | 0.135 | 7.91 | log | ClinicalTrials.gov | |
| Number needed to treat, for one more participant with the outcome on Women Who Enrolled in EAQ201 than on Women Who Enrolled in TMIST | 465 | from the risk difference interval | the interval includes no difference | ClinicalTrials.gov |
Groups 2
Neither group, or both, names a comparator, so the groups keep ClinicalTrials.gov's order.
| Group | Title | Description | With the outcome | Analysed | ClinicalTrials.gov code | Source |
|---|---|---|---|---|---|---|
| Group 1 | Women Who Enrolled in EAQ201 | Women who declined TMIST and enrolled in EAQ201 | 1 | 14 | OG000 | ClinicalTrials.gov |
| Group 2 | Women Who Enrolled in TMIST | Women who enrolled in TMIST in the same time period (March 14 20222 to Feb 2, 2023) | 1,138 | 16,427 | OG001 | ClinicalTrials.gov |
Outcome 5
| Field | Value | Source |
|---|---|---|
| Type | SECONDARY | ClinicalTrials.gov |
| Title | Compare the Proportion of WOC in TMIST Participants vs EAQ201 Participants | ClinicalTrials.gov |
| Description | The proportions will be determined by calculating the number of women who self-report as non-White versus the total number of participants enrolled. | ClinicalTrials.gov |
| Time frame | baseline | ClinicalTrials.gov |
| Population | ClinicalTrials.gov |
Trial 8
| Field | Value | Source |
|---|---|---|
| Title | COVID-19 Related Financial Hardship and Distress in Women Who Decline TMIST (EA1151) Participation | ClinicalTrials.gov |
| NCT number | NCT05076266 | ClinicalTrials.gov |
| Phases | ClinicalTrials.gov | |
| Conditions | Breast Cancer, NOS | ClinicalTrials.gov |
| Interventions | Questionnaire | ClinicalTrials.gov |
| Lead sponsor | Eastern Cooperative Oncology Group | ClinicalTrials.gov |
| Results first posted | 2025-02-10 | ClinicalTrials.gov |
| Results on ClinicalTrials.gov | https://clinicaltrials.gov/study/NCT05076266?tab=results | ClinicalTrials.gov |
Source 4
| Field | Value | Source |
|---|---|---|
| Release | trial-comparisons-2026-03-23-0.1.0 | ClinicalTrials.gov |
| Release manifest SHA-256 | f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57 | ClinicalTrials.gov |
| AACT copy | 2026-03-23 | ClinicalTrials.gov |
| Tables read | outcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquet | ClinicalTrials.gov |
Release trial-comparisons-2026-03-23-0.1.0
ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.
ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.